Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

Recruiting

Phase 1

Phase 2

Inulin Gel, Ipilimumab, NivolumabInulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

Sponsor:

University of Michigan Rogel Cancer Center

Code:

NCT06866262

Conditions

Locally Advanced Clear Cell Renal Cell Carcinoma

Locally Advanced Sarcomatoid Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

Metastatic Sarcomatoid Renal Cell Carcinoma

Stage III Renal Cell Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Inulin

Ipilimumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by University of Michigan Rogel Cancer Center on 2025-09-09.